Who invested in Hyperion Therapeutics?
Hyperion Therapeutics's investors include New Enterprise Associates, Highland Capital Partners, Sofinnova Investments, Bay City Capital and EQT life science, and 3 more on record.
United States · Funded startup
6 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$153Mraised across 6 rounds since 2007, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $7.5M sold, first sale Oct 2011
No investor was named in the report.
Reported by sec.govSEC filing: $17M sold, first sale Apr 2011
Reported by fiercebiotech.comSEC filing: $22M sold, first sale Jun 2009
No investor was named in the report.
Reported by deals.venturebeat.comSEC filing: $13M sold, first sale Aug 2008
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Hyperion Therapeutics's investors include New Enterprise Associates, Highland Capital Partners, Sofinnova Investments, Bay City Capital and EQT life science, and 3 more on record.
Hyperion Therapeutics has raised $153M across 6 rounds since 2007.
Hyperion Therapeutics's most recent round was a Debt of $7.5M in Nov 2011.
Hyperion Therapeutics's largest round on record is $60M (Series C), in Jun 2009.
Hyperion Therapeutics's first round on record, in Sept 2007, was backed by New Enterprise Associates, Highland Capital Partners and Sofinnova Investments and 1 others.
Hyperion Therapeutics's latest named round is a Debt, in Nov 2011.
Hyperion Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.